{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Antonio&page=28&state=Texas", "query": { "state": "Texas", "city": "San Antonio", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 3154, "total_pages": 316, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Antonio&page=29&state=Texas&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Antonio&page=27&state=Texas&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T01:27:42.674Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02636946", "title": "A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Open-Angle Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost SR", "type": "DRUG" }, { "name": "Sham Bimatoprost SR", "type": "DRUG" }, { "name": "Selective Laser Trabeculoplasty", "type": "PROCEDURE" }, { "name": "Sham Selective Laser Trabeculoplasty", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 144, "start_date": "2016-02-24", "completion_date": "2021-01-26", "has_results": true, "last_update_posted_date": "2022-02-23", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 21, "location_summary": "Dothan, Alabama • Chandler, Arizona • Redding, California + 17 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Redding", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02636946" }, { "nct_id": "NCT01967069", "title": "A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "DFD01 Spray", "type": "DRUG" }, { "name": "Vehicle Spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Primus Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 277, "start_date": "2013-11", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2024-03-07", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 28, "location_summary": "Mobile, Alabama • Tempe, Arizona • Oceanside, California + 24 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01967069" }, { "nct_id": "NCT04987203", "title": "Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Cell Carcinoma" ], "interventions": [ { "name": "Tivozanib", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AVEO Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 343, "start_date": "2021-09-09", "completion_date": "2026-01-20", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 36, "location_summary": "Duarte, California • Irvine, California • La Jolla, California + 31 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04987203" }, { "nct_id": "NCT00021242", "title": "Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 12, "start_date": "2002-08", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2014-08-08", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 200, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 148 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00021242" }, { "nct_id": "NCT05322941", "title": "Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Marijuana Abuse" ], "interventions": [ { "name": "AEF0117", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aelis Farma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 333, "start_date": "2022-05-06", "completion_date": "2024-07-22", "has_results": false, "last_update_posted_date": "2024-07-30", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Garden Grove, California • Los Angeles, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Lauderhill", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05322941" }, { "nct_id": "NCT00655356", "title": "Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bilateral Nasolabial Fold Wrinkles" ], "interventions": [ { "name": "Autologous Human Fibroblasts (azficel-T)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Castle Creek Biosciences, LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 218, "start_date": "2006-11", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2012-03-13", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 6, "location_summary": "Beverly Hills, California • San Diego, California • Snellville, Georgia + 3 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Snellville", "state": "Georgia" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00655356" }, { "nct_id": "NCT01303796", "title": "A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Sapacitabine", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cyclacel Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "70 Years", "maximum_age": null, "sex": "ALL", "summary": "70 Years and older" }, "enrollment_count": 482, "start_date": "2011-10-01", "completion_date": "2017-07-31", "has_results": true, "last_update_posted_date": "2022-06-22", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 39, "location_summary": "Birmingham, Alabama • La Jolla, California • Los Angeles, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01303796" }, { "nct_id": "NCT03948646", "title": "Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Axillary Hyperhidrosis" ], "interventions": [ { "name": "Sofpironium Bromide, 15%", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Botanix Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 351, "start_date": "2020-12-04", "completion_date": "2021-08-13", "has_results": true, "last_update_posted_date": "2024-05-21", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Glendale, Arizona • North Little Rock, Arkansas + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Centennial", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03948646" }, { "nct_id": "NCT00959283", "title": "Study of Blood Samples From Newborns With Down Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myeloid Proliferations Associated With Down Syndrome" ], "interventions": [ { "name": "Diagnostic Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Pharmacological Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "90 Days", "sex": "ALL", "summary": "Up to 90 Days" }, "enrollment_count": 180, "start_date": "2009-02-23", "completion_date": "2023-09-30", "has_results": false, "last_update_posted_date": "2023-10-03", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 173, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 130 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00959283" }, { "nct_id": "NCT02562716", "title": "S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Adenocarcinoma", "Resectable Pancreatic Carcinoma" ], "interventions": [ { "name": "Fluorouracil", "type": "DRUG" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Irinotecan Hydrochloride", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Paclitaxel Albumin-Stabilized Nanoparticle Formulation", "type": "DRUG" }, { "name": "Pancreatectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 147, "start_date": "2016-01-06", "completion_date": "2022-09-26", "has_results": true, "last_update_posted_date": "2022-10-19", "last_synced_at": "2026-11-06T01:27:42.674Z", "location_count": 807, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 515 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02562716" } ] }